ArticleScientific reports2025

Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humans.

Haru Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.